Company / Net Income
Biohaven Ltd. Net Income History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$846.4M
FY2024
5-year range
-$846.4M / -$118.7M
FY2020-FY2024
Trend
-107.4%
vs FY2023
Sector context
#208 of 216
Health Care
What the data says
Among 216 Health Care companies, Biohaven Ltd. is in the bottom 4% for net income. Declined from -$570M to -$846M over the past 2 years.
Based on SEC 10-K filings.
-$846M in FY2024.
Declined from -$570M to -$846M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 216This company -$846.4M Sector average $454.1M
▼
-286.4% below sector average
Key checks
Key Insights
- In FY2024, net income decreased 107.4% year-over-year.
- Ranks #208 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$846.4M | -107.4% |
| FY2023 | -$408.2M | +28.4% |
| FY2022 | -$570.3M | -166.7% |
| FY2021 | -$213.8M | -80.2% |
| FY2020 | -$118.7M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026